描述 |
托吡卡胺-d3是氘标记的托吡卡酰胺[1]。托吡卡胺(Ro 1-7683)是一种选择性M4毒蕈碱乙酰胆碱受体拮抗剂。托吡卡胺作为滴眼液使用时会产生短效散瞳(瞳孔扩张)和睫状肌麻痹[2][3]。
|
相关类别 |
|
体外研究 |
氢、碳和其他元素的稳定重同位素已被掺入药物分子中,主要作为药物开发过程中定量的示踪剂。头韵因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
|
参考文献 |
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Lazareno, S., N.J. Buckley, and F.F. Roberts, Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol Pharmacol, 1990. 38(6): p. 805-15. [3]. Hernandez, M., et al., Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter. Br J Pharmacol, 1993. 110(4): p. 1413-20.
|